Bank Of America Corp Hookipa Pharma Inc. Transaction History

Bank Of America Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.59 - $1.04 $545 - $962	-925 Reduced 14.44%	5,480 $3,000
Q1 2024 May 15, 2024	SELL	$0.61 - $0.83 $28 - $39	-47 Reduced 0.73%	6,405 $4,000
Q4 2023 Feb 14, 2024	SELL	$0.42 - $0.86 $93 - $191	-223 Reduced 3.34%	6,452 $5,000
Q2 2023 Aug 14, 2023	SELL	$0.71 - $1.97 $300,230 - $833,034	-422,860 Reduced 98.45%	6,675 $5,000
Q1 2023 May 12, 2023	BUY	$0.72 - $1.03 $3,743 - $5,354	5,199 Added 1.23%	429,535 $317,000
Q4 2022 Feb 10, 2023	SELL	$0.73 - $14.6 $17,490 - $349,816	-23,960 Reduced 5.34%	424,336 $343,000
Q3 2022 Nov 14, 2022	SELL	$1.27 - $15.0 $3,806 - $44,955	-2,997 Reduced 0.66%	448,296 $601,000
Q2 2022 Aug 12, 2022	SELL	$1.33 - $2.31 $128,713 - $223,554	-96,777 Reduced 17.66%	451,293 $735,000
Q1 2022 May 16, 2022	SELL	$1.26 - $2.52 $216,544 - $433,089	-171,861 Reduced 23.87%	548,070 $1.25 Million
Q4 2021 Feb 08, 2022	BUY	$2.33 - $5.94 $1.56 Million - $3.99 Million	671,251 Added 1378.91%	719,931 $1.68 Million
Q3 2021 Nov 15, 2021	SELL	$5.89 - $9.35 $47,720 - $75,753	-8,102 Reduced 14.27%	48,680 $287,000
Q2 2021 Sep 13, 2021	BUY	$9.16 - $19.51 $520,123 - $1.11 Million	56,782 New	56,782 $520,000

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $98.7M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.